Founded in 2005, Korea Institute for Pharmaceutical Policy Affairs, KIPPA, is a non-profit, public foundation, approved by the Korean Ministry of Health and Welfare. The institute is contributed by three relevant parties, the Korean Pharmaceutical Association (KPA), the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KBPMA), and the Korea Pharmaceutical Distribution Association (KPDA).

KIPPA is a leading research center, which aims to promote public health through the development of policy regarding the rational use of medicines, pharmacy education, pharmacy practice, pharmaceutical industry, and pharmaceutical supply and distribution. In particular, we begin to develop ¡®a community pharmacy model as a health promotion center for community members¡¯. We are collecting and analysing big data accordingly to develop pharmacy-based policies, which pursue maximised pharmacy practice for all the Koreans.

In consequence, KIPPA will consistently implement research tailored to the promotion of health in the nation and worldwide. We kindly ask for supports from our fellow pharmacists, public and associations.

If you have any further enquiries about the institute or research in English, please contact us via e-mail (kippa.org@gmail.com).

Thank you.

Office Address
3FL, 194, Hyoryeong-ro, Seocho-gu, Seoul, Repbulic of Korea

ÇöÀçÀ§Ä¡ : Home : ¾Ë¸²¸¶´ç : ¿¬±¸¼Ò ´º½º
   
¾Ë¸²¸¶´ç
°øÁö»çÇ×
º¸µµÀÚ·á
ÀÎÀçä¿ë
 
 
Á¦   ¸ñ [´ëÇѾà»çÀú³Î] ¾à±¹ ó¹æÁýÁßµµ º¯È­¿Í ¾à±¹¾à»çÀÇ »çȸÀû ¿ªÇÒ Ãß±¸
³»   ¿ë

¾à±¹ ó¹æÁýÁßµµ º¯È­¿Í ¾à±¹¾à»çÀÇ »çȸÀû ¿ªÇÒ Ãß±¸

º» °í¿¡¼­´Â Áö³­ 2020³â 2¿ù ¹ß°£µÈ 'ÀǾàǰÁ¤Ã¥¿¬±¸' 14±Ç 2È£ [³í´Ü] ¿¡ ½Ç·È´ø <¾à±¹ Ã³¹æÁýÁßµµ º¯È­¿Í ¾à±¹¾à»çÀÇ »çȸÀû ¿ªÇÒ Ãß±¸> ¿ø°í¸¦ ¿øÀúÀÚÀÇ ½ÂÀÎÀ» ¹Þ¾Æ, ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò ¸®Æ÷Æ® ÇмúÁö¸éÀ» ÅëÇØ Àç¼Ò°³ÇϰíÀÚ ÇÑ´Ù. 'ÀǾàǰÁ¤Ã¥¿¬±¸'´Â ÀǾàǰ °³¹ß, »ý»ê, À¯Åë ¹× »ç¿ë°ú °ü·ÃµÈ Á¤Ã¥Àû À̽´¸¦ ±íÀÌ ÀÖ°Ô ¿¬±¸, ºÐ¼®ÇØ ÇÕ¸®ÀûÀΠÁ¤Ã¥À» Á¦½ÃÇϰíÀÚ 2006³â Ã¢°£µÈ ÀÌ·¡ ¿¬ 2ȸ ²ÙÁØÈ÷ ¹ßÇàµÇ°í Àִ Á¤±â°£Ç๰ÀÌ´Ù. [ÆíÁýÀÚ ÁÖ]

¥°. ¼­·Ð
ÀǾàºÐ¾÷ÀÌ ³»³âÀ̸é 20³âÀÌ µÈ´Ù. ÀÌ ±ÛÀº ÀǾàºÐ¾÷ ÀÌÈÄ ¾à±¹ÀÇ ÀÇ·á±â°ü ÀÇÁ¸¼ºÀ» Ã³¹æÁýÁßµµ º¯È­·Î °üÂûÇØ º¸°í, ´Ù¸¥ ÇÑÆí ¾à±¹¿¡¼­ ½ÇõÇϰí Àִ ÃÖ±ÙÀÇ ¿©·¯ È°µ¿µéÀ» Á¤¸®ÇØ, ±× Àǹ̸¦ »ìÆìº¸°íÀÚ Çß´Ù. 

Àα¸°í·ÉÈ­¿Í ÀǾàǰ ±â¼ú º¯È­, ±×¸®°í ³ô¾ÆÁ® °¡´Â ÀÇ·áºñ µî È¿°úÀûÀΠ¾à¹° »ç¿ëÀÌ ¾î´À ¶§º¸´Ù Áß¿äÇØÁö´Â ½ÃÁ¡¿¡¼­ ÀǾàºÐ¾÷ ÀÌÈÄ ¾à±¹¾à»ç Àü¹®Áö½ÄÀÇ »çȸÀû °¡Ä¡¸¦ ³ôÀ̴ Ȱµ¿ÀÇ ±â¹ÝÀ» ¾îµð¿¡ ÁýÁßÇØ¾ß ÇÏ´ÂÁö¿¡ ´ëÇØ °íÂûÇØ º¸¾Ò´Ù. 

¥±. º»·Ð
1. Ã³¹æÁýÁßµµ¿Í ¾à±¹ÀÇ ÀÇ·á±â°ü ÀÇÁ¸¼º
°Ç°­º¸Çè Àڷᠺм® °á°ú, 2002³â ÀÌÈÄ 2018³â±îÁö Áö³­ 17³â °£ Àü±¹ ¾à±¹ÀǠó¹æÁýÁßµµ´Â ²ÙÁØÈ÷ Áõ°¡ÇØ ¿ÔÀ½À» È®ÀÎÇß´Ù. 

¾à±¹º° »óÀ§ 1°³ Ã³¹æ±â°üÀÇ ÁýÁßµµ´Â 2002³â Æò±Õ 55%¿¡¼­ 2018³â 71%·Î ²ÙÁØÈ÷ Áõ°¡Çß´Ù. 

¾à±¹º° »óÀ§ 3°³ Ã³¹æ±â°üÀÇ ÁýÁßµµ ¿ª½Ã 2002³â Æò±Õ 76%¿¡¼­ 2018³â 88%·Î Áõ°¡Çß´Ù. 

¾à±¹ÀÇ Á¶Á¦¸ÅÃâ¾×ÀÇ ´ëºÎºÐÀÌ 1°³ÀǠ󹿱â°ü¿¡ ÀÇÁ¸Çϰí ÀÖÀ½À» ¾Ë ¼ö ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ ÀÇÁ¸µµ´Â ´õ¿í °­È­µÇ°í ÀÖ´Ù. 

°æÀïÁö¼ö(HHI)·Î »ìÆìº» Ã³¹æÁýÁßµµ ¿ª½Ã 2002³â 42%¿¡¼­ 2018³â 60%·Î Áõ°¡Çß´Ù. 

HHI´Â µ¶Á¡ ¼öÁØÀ» °¡´ÆÇÒ ¼ö Àִ ÁöÇ¥·Î ¾à±¹¿¡¼­ Á¶Á¦Çϴ ó¹æÀüÀ̠ƯÁ¤ ÀÇ·á±â°ü¿¡ ÁýÁߵǴ °æÇâÀÌ °­ÇØÁüÀ» ÀǹÌÇÑ´Ù<±×¸²1>.


¾à±¹ÀÇ Á¶Á¦ ÆÐÅÏÀº ¾à±¹ÀÇ ±Ô¸ð¿¡ µû¶ó ´Ù¸¦ °ÍÀÓÀ» °¡Á¤ÇØ, ¾à±¹ÀÇ Á¶Á¦¸ÅÃâ¾× ¼øÀ§¸¦ ±âÁØÀ¸·Î 5ºÐÀ§ ±×·ìÀ» ³ª´« ÈÄ, Ã»±¸¾× ÃÖ»óÀ§ 1ºÐÀ§¿Í Ã»±¸¾× ÃÖÇÏÀ§ 5ºÐÀ§ ±×·ìº° Ã³¹æÁýÁßµµ ÃßÀ̸¦ °ËÅäÇß´Ù. 

û±¸¾× »óÀ§ 1ºÐÀ§ ¾à±¹ÀǠó¹æÀü ÁýÁßµµ´Â ´õ¿í Å©°Ô Áõ°¡ÇؿԴٴ °ÍÀ» ¾Ë ¼ö Àִµ¥, »óÀ§ 1°³ Ã³¹æ±â°ü ÁýÁßµµ°¡ 2002³â 57%¿¡¼­ 2018³â 74%·Î Áõ°¡ÇØ Àüü ¾à±¹°ú À¯»çÇßÀ¸³ª, »óÀ§ 3°³ Ã³¹æ±â°üÁýÁßµµ°¡ 2002³â 79%¿¡¼­ 2018³â 90%·Î Áõ°¡Çß°í, À̴ Àüü ¾à±¹¿¡ ºñÇØ ³ôÀº ¼öÁØÀ̾ú´Ù<±×¸²2>.


û±¸¾× »óÀ§ 5ºÐÀ§´Â °¡Àå ¿µ¼¼ÇÑ ±Ô¸ðÀÇ ¾à±¹µé·Î º¼ ¼ö Àִµ¥, À̵頾౹ÀǠ󹿱â°ü ÁýÁßµµ´Â ÀǾàºÐ¾÷ Ãʱ⠴ٸ¥ ¾à±¹µé¿¡ ºñÇØ ³·Àº ¼öÁØÀ̾úÀ¸³ª, ½Ã°£ÀÌ Áö³²¿¡ µû¶ó Áõ°¡Çß´Ù. 

ƯÈ÷ ÃÖ±ÙÀÇ °æÇâÀ» º¸¸é, ¿µ¼¼ÇÑ ¾à±¹µéÀº ¼Ò¼öÀǠ󹿱â°ü¿¡ ÀÇÁ¸µµ°¡ ¸Å¿ì ³ôÀº °æ¿ì(Ãþ¾à±¹ µî)¿Í Æ¯Á¤ Ã³¹æ±â°ü¿¡ ÀÇÁ¸ÇÏÁö ¾Ê´Â °æ¿ì(µ¿³×¾à±¹ µî)°¡ º¹ÇÕÀûÀ¸·Î Á¸ÀçÇϰí ÀÖ¾î À̵éÀº ¾à±¹ÀÇ °æ¿µ¹æ½Ä ÀÚü°¡ À̺ÐÈ­µÆÀ½À» ¸»ÇØÁÖ°í ÀÖ´Ù<±×¸²3>. <´ÙÀ½È£¿¡ °è¼Ó>

[±â»çÃâó] https://www.kpanews.co.kr/academy/show.asp?page=1&search_cate=8&idx=459

 

¹øÈ£ ÷ºÎ Á¦¸ñ ÀÛ¼ºÀÚ ÀÛ¼ºÀÏ Á¶È¸
92 [¸ÞµðÆÄ³ª´º½º]'Äڷγª19 ´ëÀÀ¡¤ÅëÇÕµ¹º½' ´Ù·é ÀǾàǰÁ¤Ã¥¿¬±¸ ¹ß°£  ±è¼±Èñ 2021-01-19 4
91 [¾à»ç°ø·Ð] ¾à±¹ °ÅÁ¡ Àڻ쿹¹æ»ç¾÷, »ý¸íÁöÅ´ÀÌ ¿ªÇÒ 'ÅåÅå'  ±è¼±Èñ 2021-01-19 2
90 [µ¥Àϸ®ÆÊ] ÀϺ»¾à±¹ÀÇ ÁøÈ­¡¦Ä«µå·Î 'Áߺ¹Åõ¾à¡¤³²Àº ¾à °ü¸®±îÁö'  ±è¼±Èñ 2021-01-19 5
89 [´ëÇѾà»çÀú³Î] ¼¼ÀÌÇÁ¾à±¹¡¤¹æ¹®¾à·á µî Ȱµ¿ Áö¼Ó Áõ°¡  ÀÌÁö¿¬ 2021-01-19 3
88 [´ëÇѾà»çÀú³Î] ¾à±¹ ó¹æÁýÁßµµ º¯È­¿Í ¾à±¹¾à»çÀÇ »çȸÀû ¿ªÇÒ Ãß±¸ ÀÌÁö¿¬ 2021-01-13 45
87 [´ëÇѾà»çÀú³Î] ÀåÁ¡Àº Ű¿ì°í ´ÜÁ¡Àº ¾ø¾Ö´Â ±³À°¹æ¹ýÀº? ÀÌÁö¿¬ 2021-01-06 77
86 [´ëÇѾà»çÀú³Î] 'Àڱ⠹ݿµ ¾ç½Ä' ÅëÇØ ¾à±¹ Àü¹®°¡ ±âÁØ ÆÄ¾Ç ÀÌÁö¿¬ 2020-12-29 80
85 [´ëÇѾà»çÀú³Î] CPD °³³ä µîÀå 80³â, ¿ì¸®³ª¶ó´Â ¾ÆÁ÷¡¦ ÀÌÁö¿¬ 2020-12-22 92
84 ¹Ì±¹¡¤¿µ±¹ ¾à»ç, ¿Â¶óÀÎÀ¸·Î ¾î¶»°Ô °øºÎÇϳª ±è¼±Èñ 2020-12-16 95
83 ÀǾàǰÁ¤Ã¥¿¬ "¿Â¶óÀÎ ¿¬¼ö±³À°¿¡ CPD µµÀÔÇØ¾ß" ±è¼±Èñ 2020-12-16 89
82 [´ëÇѾà»çÀú³Î] CPD °³³ä µîÀå 80³â, ¿ì¸®³ª¶ó´Â ¾ÆÁ÷¡¦ ÀÌÁö¿¬ 2020-12-16 77
81 [´ëÇѾà»çÀú³Î] Áö¿ª ¿©°Ç ¸ÂÃá 'Ä¡¸Å¾È½É¸¶À»'+'Ä¡¸Å¾È½É¾à±¹' ¿î¿µ ÀÌÁö¿¬ 2020-12-08 98
80 [´ëÇѾà»çÀú³Î] È£ÁÖ ¾à±¹ÀÇ Ä¡¸Å Äɾî Àü·«Àº? ÀÌÁö¿¬ 2020-12-01 109
79 [¾à»ç°ø·Ð] Ä¡¸Å±¹°¡Ã¥ÀÓÁ¦ '¿Ö ¾à»ç´Â ºüÁ³À»±î'¡¦¿Ü±¹Àº ¾î¶»°Ô? ±è¼±Èñ 2020-11-25 127
78 [µ¥Àϸ®ÆÊ] ³â µÚ Ä¡¸ÅÀα¸ 100¸¸ ½Ã´ë¡¦¾à±¹ ¿ªÇÒÀ» ã¾Æ¶ó ±è¼±Èñ 2020-11-25 129

ÀÌÀü 10ÆäÀÌÁö [1]  [2]  [3]  [4]  [5]  [6]  [7]  ´ÙÀ½ 10ÆäÀÌÁö

 
 

¼­¿ï ¼­Ãʱ¸ È¿·É·Î194, 3Ãþ (Àç)ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò TEL : 02) 3474-5301 / FAX : 02)3474-5306

COPYRIGHT (C) 2006 KOREA INSTITUTE FOR PHARMACEUTICAL POLICY AFFAIRS ALL RIGHTS RESERVED. FOR MORE INFORMATION MAL kippa.org@gmail.com

±âºÎ±Ý ¾È³»